Medicine Foundation provides support to cancer patients, families seeking access to targeted therapies

Medicine Foundation provides support to cancer patients, families seeking access to targeted therapies -

Medicine Foundation, Inc. (NASDAQ: IMF) announced today ' hui that it has entered a partnership with the lawyer's patients Foundation (PAF) on a national program to provide assistance to cancer patients and their families seeking access to targeted therapies. The program, called FoundationOne® CareLine, offers personalized case management services to patients who are uninsured, underinsured or face other challenges that affect their access to care, and increases the ability of physicians to act on the FoundationOne results.

Adoption of FoundationOne by academic and community oncologists supports the clinical utility needed to improve outcomes and quality of life for certain groups of patients who may benefit from targeted health treatment. However, it can sometimes be difficult for patients and their doctors to have access to appropriate treatment and potentially save lives.

"The rapid evolution of genomics and the scientific understanding of cancer in recent years have fundamentally changed the way cancer can be treated, but sometimes progress evidenced by new medical and scientific data exceeded access to treatment, "said Deborah Morosini, MD, Vice President clinical development, Medicine Foundation." Through this partnership with the lawyer's patients Foundation, FoundationOne CareLine connects patients in case of resources management that help them navigate through the proper channels to get treatments by harnessing the peer reviewed literature supporting its use. "

The FoundationOne CareLine is an expansion of a pilot effort between Medicine Foundation and the PAF has supported patients from some great doctors, and resulted in nearly $ 400,000 in reimbursement guaranteed medical expenses for patients. Under the expanded program, clinical case managers will continue to provide comprehensive case management services to uninsured patients, underinsured and insured who face obstacles obtaining prescribed targeted therapies that are approved in an indication other than the type of patient's tumor. Other services include assistance navigating the reimbursement system to help cover the costs associated with FoundationOne test and the costs of auxiliary treatment, education and clinical trials of screening and assistance for patients seeking access to experimental treatments under compassionate use.

"for case managers Foundation patients improve the lives of patients and help ensure that the required medical care is within reach by providing the appropriate evidence to payers to ensure access to treatment" said Alan Balch, CEO of counsel patients Foundation. "Through this partnership, Medicine Foundation supports the valuable case management services that make a significant difference in the lives of cancer patients seeking access to targeted therapies that their doctors believe will have a significant impact in the treatment of their disease. "